Document gDz9E8qEnn0j28NBvEgYj0kJ9

CHEMICAL MANUFACTURERS ASSOCIATION Vinyl Chloride Health Committee Record of Meeting with Applied Epidemiology Inc. Date: Time: Place: December 5,1994 8:30 a.m. Lord Jeffrey Inn Amherst, MA List of Attendees: Carol Bigelow Linda Dell Kenneth Mundt Rainer Noess Jonathan Ramlow Applied Epidemiology Inc. Applied Epidemiology Inc. Applied Epidemiology Inc. Applied Epidemiology Inc. Dow Chemical Has Shah CMA 1.0 The objective of the meeting was to discuss the September 1,1994 technical and administrative proposals from Applied Epidemiology Inc., and to receive a demonstration of the ProQuest software program used by AEI for epidemiology study information management. 2.0 Has Shah will identify key people from the Vinyl Chloride Panel member companies to expedite information gathering by the contractor for the epidemiology study update. Kenneth Mundt identified the following industry people who have or are working with him on vinyl chloride issues: Bob Gilligan Joe Ledvina Tom Grumbles David Penney Jane Teta OxyChem Vista Chemical Vista Chemical Vista Chemical Union Carbide 3.0 Jonathan Ramlow discussed the possibility of industry supporting a nested case control brain cancer study of vinyl chloride workers at the University of Louisville under the supervision of Dr. Carlo Tamburro. If the study is sponsored by the industry. Applied Epidemiology Inc., or any other selected contractor, the contractor may need to work with Dr. Tamburro to cost- CMA 022562 ROM VHC December 5,1994 Page 2 effectively complete both projects. Dr. Shah will send the relevant literature published by Dr. Tamburro to Dr. Mundt. 4.0 The following issues/action items were identified for follow-ups: Dr. Shah will discuss with ENSR the process for transferring the vinyl chloride epidemiology data to another contractor. Dr. Ramlow will follow-up with the National Death Index to see if the death certificate confidentiality agreements signed by Otto Wong with specific states or the National Death Index can be waived when transferring data from ENSR to another contractor selected by CMA for the update of the epidemiology study. If the response is affirmative, Dr. Ramlow will draft a form letter to obtain confidentiality waivers from the Group C states. Dr. Mundt will develop a procedure to be followed by participating companies to establish vital status of the vinyl chloride cohort that was alive as of 1982. Dr. Mundt will investigate the availability and cost of storage space for records and raw data from the epidemiology study for a period of ten years following the completion of the study. 5.0 Rainer Noess demonstrated the ProQuest software program for epidemiology study information management. 6.0 The meeting concluded at approximately 1:15 p.m. Subject to Approval Hasmukh C. Shah, Ph.D. Manager, Vinyl Chloride Panel CMrt 022563